Adigong Maternal and Child Health Co., Ltd. ("Adigong") announced that the final deadline for the new share offering, originally scheduled to end on August 15, 2024, will be extended to September 15, 2024. This offering sells up to 44,350,000 new shares issued under the company's special authorization. The reason for the extension is that the offering agent needs more time to find investors and complete related administrative procedures. Adigong and the offering agent reached an extension agreement after the trading period on August 15, 2024. The company emphasized that, in addition to the extended deadline, all other terms and conditions of the offering agreement remain unchanged. Shareholders and potential investors are reminded that the completion of the offering is still subject to the conditions in the offering agreement and warned to be cautious when trading shares.

Adigong Maternal and Child Health Co., Ltd. ("Adigong") announced that the final deadline for the new share offering, originally scheduled to end on August 15, 2024, will be extended to September 15, 2024. This offering sells up to 44,350,000 new shares issued under the company's special authorization. The reason for the extension is that the offering agent needs more time to find investors and complete related administrative procedures. Adigong and the offering agent reached an extension agreement after the trading period on August 15, 2024. The company emphasized that, in addition to the extended deadline, all other terms and conditions of the offering agreement remain unchanged. Shareholders and potential investors are reminded that the completion of the offering is still subject to the conditions in the offering agreement and warned to be cautious when trading shares.